![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 5/077 | |
C12N 5/0775 | |||
A61K 35/35 | |||
A61K 35/28 | |||
A61P 17/00 | |||
A61P 37/00 | |||
A61P 43/00 |
(11) | Number of the document | 3046417 |
(13) | Kind of document | T |
(96) | European patent application number | 14845486.1 |
Date of filing the European patent application | 2014-09-17 | |
(97) | Date of publication of the European application | 2016-07-27 |
(45) | Date of publication and mention of the grant of the patent | 2017-07-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/056145 |
Date | 2014-09-17 |
(87) | Number | WO 2015/042182 |
Date | 2015-03-26 |
(30) | Number | Date | Country code |
201361880086 P | 2013-09-19 | US | |
201461977466 P | 2014-04-09 | US |
(72) |
FRASER, John, US
MAGALON, Guy, US
|
(73) |
Cytori Therapeutics, Inc.,
3020 Callan Road, San Diego, California 92121,
US
|
(54) | METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF RAYNAUD`S PHENOMENON ASSOCIATED WITH SCLERODERMA |
METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF RAYNAUD`S PHENOMENON ASSOCIATED WITH SCLERODERMA |